Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Settles Patent Infringement Suit with Caliper

NEW YORK, Nov. 4 (GenomeWeb News) - Molecular Devices today said it has settled a patent infringement lawsuit filed by Caliper Technologies in 2002 involving Molecular Devices' IMAP kinase assay products.

Under the terms of the settlement, Molecular Devices has agreed to pay Caliper a one-time licensing fee as well as royalties based on future sales of IMAP products.

Further details of the settlement were not disclosed.

The lawsuit alleged that Molecular Devices' IMAP assay products infringed Caliper's US Patent Nos. 6,287,774 and 6,472,141, which cover methods and systems for performing assays in which the reaction product has a different charge than the substrate. The product or substrate is bound to a polyionic component, and the binding is detected by conventional methods, including fluorescence polarization.


The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.